Xtant Medical Holdings, INC 10-K annual reports

Xtant Medical Holdings, Inc. achieved net income in 2025 driven by license revenue and orthobiologics sales, despite divesting Coflex/CoFix assets and international hardware business, which will impact 2026 revenues.

Xtant Medical Holdings, Inc. reports a revenue increase for fiscal year 2024 driven by acquisitions and licensing agreements, but also reports a net loss due to increased operating expenses and interest expense.

Xtant Medical Holdings extends the termination deadline for its asset purchase agreement with Surgalign and files its annual 10-K report detailing financial results and strategic initiatives.